1. Home
  2. CWCO vs PRME Comparison

CWCO vs PRME Comparison

Compare CWCO & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Water Co. Ltd.

CWCO

Consolidated Water Co. Ltd.

HOLD

Current Price

$30.34

Market Cap

478.2M

Sector

Utilities

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$2.95

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWCO
PRME
Founded
1973
2019
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Water Supply
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.2M
536.4M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
CWCO
PRME
Price
$30.34
$2.95
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$40.00
$7.56
AVG Volume (30 Days)
75.3K
4.0M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
18.18
EPS
0.23
N/A
Revenue
$132,073,368.00
$4,632,000.00
Revenue This Year
$4.34
$7.06
Revenue Next Year
$42.86
$47.01
P/E Ratio
$128.35
N/A
Revenue Growth
N/A
55.28
52 Week Low
$28.17
$2.67
52 Week High
$39.12
$6.94

Technical Indicators

Market Signals
Indicator
CWCO
PRME
Relative Strength Index (RSI) 62.20 40.88
Support Level $30.09 $2.68
Resistance Level $30.69 $3.68
Average True Range (ATR) 0.46 0.24
MACD 0.15 -0.08
Stochastic Oscillator 88.22 7.75

Price Performance

Historical Comparison
CWCO
PRME

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: